PMS2 mutation
|
Gastric Cancer
|
PMS2 mutation
|
Gastric Cancer
|
CP-675206 Sensitive: C2 – Inclusion Criteria
|
CP-675206 Sensitive: C2 – Inclusion Criteria
|
PMS2 mutation
|
Gastric Cancer
|
PMS2 mutation
|
Gastric Cancer
|
durvalumab Sensitive: C2 – Inclusion Criteria
|
durvalumab Sensitive: C2 – Inclusion Criteria
|
PMS2 mutation
|
Germ Cell Tumors
|
PMS2 mutation
|
Germ Cell Tumors
|
camrelizumab Sensitive: C4 – Case Studies
|
camrelizumab Sensitive: C4 – Case Studies
|